25.08.2015 08:24:00
|
Astellas Pharma Inc. -- Moody's: Japan's increasing use of generics will pressure pharmaceutical earnings; drive cross-border M&As
Tokyo, August 25, 2015 -- Moody's Japan K.K. says that Japan's five-largest pharmaceutical companies by revenue will see revenue contributions from the Japanese market contract over the next five years because of the increasing use of generic drugs in the country.